The Autism Candidate Gene Neurobeachin Encodes a Scaffolding Protein Implicated in Membrane Trafficking and Signaling

Author(s): K. Volders, K. Nuytens, J. W.M. Creemers

Journal Name: Current Molecular Medicine

Volume 11 , Issue 3 , 2011

Become EABM
Become Reviewer
Call for Editor


Autism is a developmental disorder of the central nervous system characterized by impairments in social interaction, communication and restricted repetitive and stereotyped behavior. It is generally assumed that in most cases autism has a polygenic cause, but the pathogenesis is still unknown. Neurobeachin (NBEA) has recently been identified as a candidate gene for autism in a patient with a de novo chromosomal translocation and three patients with a monoallelic deletion. This multidomain scaffolding protein has been suggested to be involved in neuronal post-Golgi membrane traffic. Knockout of Nbea in two independent mouse models has demonstrated a role in neurotransmitter release and synaptic functioning. Knockdown in a cell line has shown a role as negative regulator of secretion of large dense-core vesicles (LDCVs) and haploinsufficiency in blood platelets results in dense granules with an aberrant morphology. A potential role in vesicle transport is further supported by a study of SEL-2, the C. elegans homologue of NBEA. This protein was identified as a negative regulator of LIN-12/Notch activity, probably due to defects in endosomal trafficking. Members of the Notch pathway have also been shown to be modifiers of the NBEA homologue in Drosophila, rugose. These new insights in the function of NBEA may help identifying novel pathways affected in autistic patients. In particular, it suggests that impaired functionality of LDCVs, which contain neurotrophins, neuropeptides and monoamines, might contribute to the pathogenesis of autism in at least a subgroup of patients.

Keywords: Neurobeachin, Rugose, SEL-2, regulated secretion, autism, Notch, EGFR, synapse, autism spectrum disorders, teratogenic drugs, fragile X syndrome, Rett syndrome, tuberous sclerosis, neurofibromatosis, mutations

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [204 - 217]
Pages: 14
DOI: 10.2174/156652411795243432
Price: $65

Article Metrics

PDF: 20